ClinicalTrials.gov
ClinicalTrials.gov Menu

"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01408771
Recruitment Status : Completed
First Posted : August 3, 2011
Last Update Posted : August 9, 2011
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center

Brief Summary:
The purpose of this study is to find out whether swallowing has an effect on the degree of urinary urgency and on the amplitude of detrusor contraction during filling cystometry in patients with detrusor overactivity (DO).

Condition or disease
Overactive Detrusor

Detailed Description:
Consecutive patients with DO will be included in this study. During urodynamics, the amplitude of the waves of DO will be documented and compared. At the beginning of the 2nd wave, patients will be asked to perform 5 repetitive swallows. Following each wave, patients will be asked to grade the severity of the urgency by a visual analogue scale (VAS).

Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: "Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver
Study Start Date : April 2011
Actual Primary Completion Date : July 2011
Actual Study Completion Date : July 2011

Resource links provided by the National Library of Medicine






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who are sedignated for urodynamic study with overactive bladder symptoms
Criteria

Inclusion Criteria:

patients with DO in filling cystometry

  • antimuscarinic medications were requested to stop for 7 days before the cystometry

Exclusion Criteria: none


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01408771


Sponsors and Collaborators
Assaf-Harofeh Medical Center
Investigators
Principal Investigator: Kobi Stav, MD Assaf Harofeh Medical Center, Zeriffin, Israel

Responsible Party: Kobi Stav, Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier: NCT01408771     History of Changes
Other Study ID Numbers: 35/11
First Posted: August 3, 2011    Key Record Dates
Last Update Posted: August 9, 2011
Last Verified: July 2011

Keywords provided by Assaf-Harofeh Medical Center:
Urodynamics
Overactive Bladder

Additional relevant MeSH terms:
Urinary Bladder, Overactive
Urinary Bladder Diseases
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms